DI
TARO

Disciplined Investments’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Disciplined Investments’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-7
Closed -$170 – 1736
2023
Q1 		$170 Buy
7
+3
+75% +$87 ﹤0.01% 1510
2022
Q4 		$116 Sell
4
-3
-43% -$89 ﹤0.01% 1520
2022
Q3 		$0 Sell
7
-1
-13% -$34 ﹤0.01% 1691
2022
Q2 		$0 Buy
8
+2
+33% +$76 ﹤0.01% 1702
2022
Q1 		$0 Buy
+6
New +$280 ﹤0.01% 1677

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return

Disciplined Investments's TARO Position: Q2 2023 in Review

Disciplined Investments sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2023, closing a stake of 7 shares — an estimated $170 sold.

Disciplined Investments first reported a position in TARO in Q1 2022 and held it in 5 quarters. The position peaked at $170 in Q1 2023. 71 funds tracked by Wall St. Rank hold TARO as of Q2 2023.

  • Disciplined Investments reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2023 after selling out during the quarter.
  • Disciplined Investments sold 7 Taro Pharmaceutical Industries Ltd. shares in Q2 2023, an estimated $170.
  • Disciplined Investments first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2022 and held it in 5 quarters.
  • Disciplined Investments's Taro Pharmaceutical Industries Ltd. position peaked at $170 in Q1 2023.
  • 71 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2023.

Based on Disciplined Investments's 13F filing for Q2 2023, filed 10 Jul 2023.